Skip to main content
Clinical Trials/NCT03748654
NCT03748654SuspendedNot Applicable

Feasibility of Visual Field Testing With a Virtual Reality Headset

Brennan Eadie1 site in 1 country30 target enrollmentStarted: January 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Visual field differential light sensitivity threshold

Study Overview

Brief Summary

This study aim to determine the feasibility of using a virtual reality (VR) headset (HTC Vive) to test the visual field. The VR headset test will be compared to a conventional visual field test, using the Humphrey Field Analyzer. The investigators will include 10 healthy patients without visual field defect, 10 patients with early glaucomatous visual field defect, and 10 patients with advanced visual field defect. Each patient will perform the conventional test twice and the VR headset test 4 times, divided in 3 visits within a 2 month period. The results of the tests (sensitivity thresholds) will be compared. The investigators hypothesize that the results of the conventional and VR tests will be similar.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Previous visual field test with Humphrey Field Analyzer indicating normal field, early glaucomatous field damage, or advanced glaucomatous field damage, according to Canadian Glaucoma Society Guidelines.
  • •Ability to understand and consent to the study.

Exclusion Criteria

  • •Presence of non-glaucomatous pathology that could influence the visual field test, such as media opacities.
  • •Previous intraocular surgery less than 6 months from inclusion.
  • •Difficulty to execute a reliable visual field test.
  • •Potential contra-indications to use of virtual reality headset, including: anxiety disorder, pregnancy, seizure disorder, cardiac pacemaker or other implantable device, severe vertigo or balance disturbance.

Arms & Interventions

Single Arm

Experimental

Patients will perform visual field testing with the Humphrey Field Analyzer and with the Virtual Reality Headset

Intervention: Visual Field Testing (Diagnostic Test)

Outcomes

Primary Outcomes

Visual field differential light sensitivity threshold

Time Frame: Three weeks

Comparison of differential light sensitivity threshold estimated with the Humphrey Field Analyzer and the Virtual Reality headset

Secondary Outcomes

  • Reproducibility of sensitivity values(Three weeks)

Investigators

Sponsor
Brennan Eadie
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Brennan Eadie

Assistant Professor, Department of Ophthalmology, Dalhousie University and Nova Scotia Health Authority; MD, PhD, FRCSC

Nova Scotia Health Authority

Study Sites (1)

Loading locations...

Similar Trials